These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28457153)

  • 1. The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia.
    Horvitz-Lennon M; Mattke S; Predmore Z; Howes OD
    Am J Psychiatry; 2017 May; 174(5):421-426. PubMed ID: 28457153
    [No Abstract]   [Full Text] [Related]  

  • 2. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
    Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
    Lopez LV; Shaikh A; Merson J; Greenberg J; Suckow RF; Kane JM
    J Clin Psychopharmacol; 2017 Jun; 37(3):310-314. PubMed ID: 28353490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.
    McCutcheon R; Beck K; D'Ambrosio E; Donocik J; Gobjila C; Jauhar S; Kaar S; Pillinger T; Reis Marques T; Rogdaki M; Howes OD
    Acta Psychiatr Scand; 2018 Jan; 137(1):39-46. PubMed ID: 29072776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms.
    McCutcheon R; Beck K; Bloomfield MA; Marques TR; Rogdaki M; Howes OD
    J Psychopharmacol; 2015 Aug; 29(8):892-7. PubMed ID: 25788157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
    Melkote R; Singh A; Vermeulen A; Remmerie B; Savitz A
    Schizophr Res; 2018 Nov; 201():324-328. PubMed ID: 29804929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Jun; 42(3):263-73. PubMed ID: 25821065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
    Brnabic AJ; Kelin K; Ascher-Svanum H; Montgomery W; Kadziola Z; Karagianis J
    Int J Clin Pract; 2011 Sep; 65(9):945-53. PubMed ID: 21849009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data.
    Takeuchi H; Suzuki T; Bies RR; Remington G; Mamo DC; Pollock BG; Mimura M; Uchida H
    Schizophr Res; 2013 Nov; 150(2-3):373-9. PubMed ID: 24028745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia.
    Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
    Curr Clin Pharmacol; 2012 Feb; 7(1):49-55. PubMed ID: 22299769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.
    Lane HY; Guo SC; Hwang TJ; Chen YS; Cheng JJ; Lee YC; Hong CJ; Hwu HG; Chang WH
    J Clin Psychopharmacol; 2002 Oct; 22(5):530-2. PubMed ID: 12352282
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-adherence to psychotropic medication assessed by plasma level in newly admitted psychiatric patients: Prevalence before acute admission.
    Geretsegger C; Pichler EM; Gimpl K; Aichhorn W; Stelzig R; Grabher-Stoeffler G; Hiemke C; Zernig G
    Psychiatry Clin Neurosci; 2019 Apr; 73(4):175-178. PubMed ID: 30552718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia.
    Lopez LV; Kane JM
    J Clin Psychiatry; 2015 Sep; 76(9):1249-50. PubMed ID: 26455671
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentrations of antipsychotics and QTc prolongation: a pilot study.
    Høimark L; Uhrskov Sørensen L; Vukelic Andersen L
    Nord J Psychiatry; 2020; 74(5):374-379. PubMed ID: 32105154
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia.
    Endriyani L; Chien CH; Huang XY; Chieh-Yu L
    Perspect Psychiatr Care; 2019 Apr; 55(2):147-152. PubMed ID: 29578605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey.
    Nagai N; Tani H; Suzuki T; Ikai S; Gerretsen P; Mimura M; Uchida H
    Pharmacopsychiatry; 2017 Nov; 50(6):264-269. PubMed ID: 28675911
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing Antipsychotic Patient Management Using Population Pharmacokinetic Models and Point-of-Care Testing.
    Green B; Korell J; Remmerie B; Savitz A; Vermeulen A
    CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):573-575. PubMed ID: 28575540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.